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ABSTRACT
By searching a chicken EST database, we identified a cDNA clone that appeared to contain the entire open
reading frame (ORF) of chicken interleukin-18 (ChIL-18). The encoded protein consists of 198 amino acids
and exhibits approximately 30% sequence identity to IL-18 of humans and various others mammals. Sequence
comparisons reveals a putative caspase-1 cleavage site at aspartic acid 29 of the primary translation product,
indicating that mature ChIL-18 might consist of 169 amino acids. Bacterially expressed ChIL-18 in which the
N-terminal 29 amino acids of the putative precursor molecule were replaced by a histidine tag induced the
synthesis of interferon-c (IFN-c ) in cultured primary chicken spleen cells, indicating that the recombinant
protein is biologically active.
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INTRODUCTION
INTERLEUKIN-18 (IL-18) WAS ORIGINALLY DESCRIBED as an in-terferon-g (IFN-g)-inducing factor and was cloned from Pro-
pionibacterium acnes-treated mouse livers in 1995.(1) In the en-
suring years, IL-18 has been characterized in great detail, as
summarized in some recent reviews.(2–4) IL-18 belongs to the
IL-1 family of cytokines. Like IL-1b, it is synthesized as a pre-
cursor molecule that lacks a typical signal peptide and is cleaved
by caspase-1 into a bioactive cytokine.(5,6) Computer modeling
studies predict that IL-18 contains many b-sheets, as does IL-
1b.(7) IL-18 binds to a heterodimeric receptor complex in which
both the binding and the signaling chain are members of the
IL-1 receptor family.(8,9) The signaling cascades of IL-18 and
IL-1b are identical, and both lead to activation of NF-kB.(10,11)
The biologic properties of mammalian IL-18 are complex.(4)
It shares properties with IL-12, as both cytokines can induce
Th1 immune responses.(4,10) The observed synergistic effects
of IL-18 and IL-12 on IFN-g induction seem to result from IL-
18 receptor upregulation by IL-12(12) and a concerted activa-
tion of the IFN-g promoter.(13) Other functions ascribed to IL-
18 include induction of IL-1b, tumor necrosis factor-a
(TNF-a), and several chemokines,(14) as well as enhancement
of natural killer (NK) cell cytotoxicity.(15) An important role
for IL-18 has been shown in several models of infectious, in-
flammatory, and autoimmune diseases, as well as in tumor
models.(4) IL-18 mRNA and precursor synthesis is constitu-
tive,(16) indicating that IL-18 activity is regulated at the level
of cytokine precursor processing and secretion. The in vivo ac-
tivity of IL-18 is further regulated by a secreted IL-18-binding
protein.(17,18) Interestingly, several poxviruses also encode sol-
uble factors that bind and neutralize IL-18, thereby interfering
with the host defense system.(19,20)
It has been unclear to date whether birds have a cytokine
with structural and functional properties of mammalian IL-18.
Here, we report the identification of a cDNA encoding a chicken
homolog of IL-18 (ChIL-18). We further show that bacterially
expressed ChIL-18 is a potent inducer of IFN-g in primary
chicken spleen cells.
MATERIALS AND METHODS
Cell culture
HD-11 cells(21) were grown in Dulbecco’s modified essen-
tial medium (DMEM) supplemented with 8% fetal bovine
serum (FBS) and 2% chicken serum. Chicken spleen cells were
prepared as described(22) and maintained in RPMI 1640 medium
supplemented with 8% FBS and 2% chicken serum at 40°C in
a CO2 incubator.
cDNA cloning
Analysis of BLAST search results of a chicken bursal EST
database (http://genetics.hpi.uni-hamburg.de/dt40.html) indi-
cated that clone dkfz426 3m9r1 contained sequence informa-
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tion for ChIL-18. To isolate a cDNA fragment containing the
complete open reading frame (ORF) for this protein, PCR was
performed with primers 59-CCCAAGCTTATGAGCTGT-
GAAGAGATCGCTGTG-3 9 and 59-TGCTCTAGATCATAG-
GTTGTGCCTTTCATTATG-3 9, which introduced HindIII and
XbaI restriction sites near the ends of the amplification prod-
uct. cDNA from HD-11 cells stimulated for 5 h with 5 mg/ml
lipopolysaccharide (LPS)(23) was used as template. The PCR
product was directionally cloned between the HindIII and the
XbaI restriction sites of vector pcDNA3 (Invitrogen, Gronin-
gen, Netherlands).
Purification of histidine-tagged ChIL-18 from
Escherichia coli
A fragment of ChIL-18 cDNA (nucleotide positions 91–600
in Fig. 1) was amplified by PCR using primers 59-CGCG-
GATCCGCCTTTTGTAAGGATAAAACT-3 9 and 59-CCCA-
AGCTTTCATAGGTTGTGCCT-3 9, which introduced unique
BamHI and HindIII restriction sites near the ends of the frag-
ment, and the PCR product was cloned between the BamHI and
HindIII restriction sites of prokaryotic expression vector pQE9
(Qiagen, Chatsworth, CA). Expression of this construct in E.
coli strain M15 yielded His-ChIL-18, which corresponds to pu-
tative mature ChIL-18 with an N-terminal extension consisting
of the peptide Met-Arg-Gly-Ser-(His)6-Gly-Ser. His-ChIL-18
was purified by affinity chromatography on a nickel chelate
agarose column. Purification conditions were as described for
ChIFN-g(24) with slight modifications. Induction was done at
OD600 5 0.8 for a period of 3 h using an isopropylthiogalactose
(IPTG) concentration of 0.5 mM. We checked for purity of 
recombinant His-ChIL-18 by standard SDS-PAGE (15% 
gel) and subsequent Coomassie blue staining.
Induction of IFN-g synthesis by His-ChIL-18 in
chicken spleen cells
Chicken spleen cells were prepared as described,(22)
seeded at a density of 2.5 3 105 cells per well of a 96-well
plate, and incubated with the indicated amounts of recombi-
nant His-ChIL-18, His-ChIL-18 that has been heat-inacti-
vated for 10 min at 100°C, or the control protein His-MxA.
At 48 h after onset of cytokine treatment, cell supernatants
were assayed for the presence of biologically active IFN-g.
For this purpose, HD-11 cells were incubated for 24 h with
samples of the various supernatants. Activation of HD-11
cells by IFN-g was measured as a function of nitrite accu-
mulation in the culture supernatants using the Griess as-
say.(25,26) To confirm that the observed nitric oxide (NO) pro-
duction was induced by IFN-g, supernatants of spleen cells
stimulated with the indicated amounts of His-ChIL-18 were
preincubated for 2 h at 37°C with a polyclonal neutralizing
antiserum to ChIFN-g(24) at a dilution of 1:200 and subse-
quently transfered to HD-11 cells.
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FIG. 1. cDNA sequence (EMBL/GenBank accession No.
AJ277865) and predicted amino acid sequence of ChIL-18. Nu-
cleotide numbering is at right. An ATTTA sequence motif in
the 39-noncoding region, which presumably mediates mRNA
instability, is underlined. The protein sequence is given in the
single letter code. Amino acid numbers are indicated below the
sequence. The propeptide that is probably cleaved off by cas-
pase-1 after the conserved aspartate residue at position 29 is
boxed.
FIG. 2. Comparison of IL-18 sequences from chicken and various mammals. Alignments were done using the Jotun Hein
method.(27) Dots represent identical amino acids, and alignment gaps are indicated by hyphens. The arrow marks the position of
a conserved aspartate residue at which caspase-1-mediated cleavage of the precursor molecules is predicted to occur.
RESULTS AND DISCUSSION
Cloning of ChIL-18 cDNA
By analyzing the BLAST search results of a chicken EST
database, we identified clone dkfz426 3m9r1, which seemed to
encode a polypeptide with significant similarity to mammalian
IL-18. PCR with cDNA from LPS-induced chicken HD-11 cells
and primers corresponding to the EST clone resulted in the am-
plification of a cDNA fragment whose nucleotide sequence
(EMBL/GenBank accession No. AJ277865) precisely matched
the sequence of the original EST clone. This cDNA codes for
a polypeptide of 198 amino acids (Fig. 1).
Alignment of ChIL-18 with IL-18 from various mammals
revealed amino acid identities of approximately 30%. A com-
parison of chicken and mammalian IL-18 sequences is shown
in Figure 2. IL-18 is synthesized as an inactive precursor in
mammals that is activated by caspase-1, which cleaves the mol-
ecule after a conserved aspartate (arrow in Fig. 2). Sequence
comparisons revealed that the critical aspartate residue is con-
served in the ChIL-18 sequence (Fig. 2), indicating that it may
also be cleaved at this residue. Mature ChIL-18 thus seems to
consist of 169 amino acids.
Recombinant His-ChIL-18 from E. coli is 
biologically active
Assuming that pro-ChIL-18 is cleaved after the conserved
aspartate residue at position 29 (Fig. 2), we used PCR to am-
plify a cDNA fragment that encodes an N-terminally truncated
form of ChIL-18. After cloning into the prokaryotic expression
vector pQE9, the resulting construct should yield a translation
product that consists of an N-terminal histidine tag followed by
the putative mature ChIL-18 sequence. This product, which we
designated His-ChIL-18, was purified from E. coli by affinity
chromatography on nickel chelate agarose beads. After elution
under nondenaturing conditions, peak column fractions were
pooled and diluted to a concentration of 0.5 mg protein per ml.
His-ChIL-18 appeared as a prominent band on SDS-PAGE at
about 23 kDa. It was more than 50% pure (Fig. 3A).
To determine whether bacterially expressed recombinant
His-ChIL-18 is biologically active, we tested its ability to in-
duce IFN-g synthesis in cultured primary chicken spleen cells.
Spleen cells were incubated with various concentrations of pu-
rified His-ChIL-18 or as negative controls with either heat-in-
activated His-ChIL-18 or an unrelated protein (His-MxA). At
48 h after onset of treatment, the spleen cell supernatants were
analyzed for the presence of IFN-g by a standard bioassay that
monitors IFN-g activity as a function of NO secretion by the
chicken macrophage cell line HD-11.(28) As shown in Figure
3B, only supernatants of spleen cells treated with nondenatured
recombinant ChIL-18 exerted macrophage-activating activity.
The minimal concentration of His-ChIL-18 that induced sig-
nificant amounts of IFN-g in spleen cells was 60 ng/ml. Treat-
ment of spleen cells with 250 ng/ml of either His-MxA or heat-
inactivated His-ChIL-18 did not cause significant secretion of
NO. In addition, neither the His-ChIL-18 nor the His-MxA
preparation induced NO synthesis when added directly to HD-
11 indicator cells at concentrations as high as 1 mg/ml (data not
shown), indicating that the observed effect was a specific ac-
tivity of ChIL-18.
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FIG. 3. Purified His-ChIL-18 from E. coli is biologically ac-
tive. (A) Coomassie blue-stained gel showing a sample of pu-
rified His-ChIL-18. The molecular sizes of marker proteins are
indicated. (B) Chicken spleen cells were treated for 48 h with
the indicated concentrations of either active His-ChIL-18, heat-
inactivated His-ChIL-18, or the control protein His-MxA.
Spleen cell supernatants were added to HD-11 cells either di-
rectly or after preincubation with a polyclonal antiserum that
neutralizes ChIFN-g in order to monitor IFN-g-induced NO se-
cretion.
Treatment of supernatants from His-ChIL-18-treated chicken
spleen cells with a polyclonal antiserum that neutralizes ChIFN-
g(24) blocked their NO synthesis-inducing activity (Fig. 3B),
demonstrating that the factor secreted by spleen cells after
treatment with ChIL-18 is indeed IFN-g.
Our discovery that chickens have a cytokine with structural
and functional similarities to mammalian IL-18 further supports
the view that most parts of the cytokine network had already
been in place when the avian and mammalian lineages sepa-
rated about 300 million years ago. In this context, it is of in-
A
B
terest to note that the various chicken cytokines for which
cDNA have to date been cloned (type I IFN,(29,30) IFN-g,(24,31)
IL-1b,(23) IL-2,(32) IL-18 [this report]) are all considered to
drive Th1 immune responses. Such cytokines as IL-4, IL-5, or
IL-10, which characterize Th2 immune responses, have to date
not been found in the chicken. It is unclear at present whether
the latter cytokines are absent from birds or were simply missed
because of the lack of appropriate assay systems.
In summary, the unlimited availability of biologically active
recombinant ChIL-18 now makes it possible to test if this cy-
tokine has the potential to modulate vaccine-induced immune
responses in chickens.
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